Clin2
NCT06665568Possibly a fitNot yet recruiting

Ketamine nasal spray for depression and anxiety in advanced cancer

Depressive Symptoms Mild to Moderate in SeverityAnxietyQuality of Life (QOL)Caregiver BurdenSleep Quality

Part of Brain & nervous system, Mental health clinical trials.

This study tests whether a ketamine nasal spray can help reduce depression and anxiety in people with advanced cancer. It also looks at how caregivers are affected. If you are living with progressive cancer and feeling down or anxious, this treatment might offer some relief.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older
  • You have a progressive cancer diagnosis with an estimated life expectancy of at least 2 years
  • You are able to attend study visits and speak and understand German
  • You have at least mild symptoms of depression or anxiety (scoring 6 or more on a standard questionnaire)
  • You have not been diagnosed with a mood disorder before your cancer, and you are not currently suicidal
  • You do not have severe heart problems, high blood pressure, or a history of nasal surgery that would interfere

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06330584Recruiting· Phase 2
Nasal spray for anxiety in palliative care

This trial tests a nasal spray called midazolam to quickly reduce anxiety in people receiving palliative care. If you're an adult in the hospital with sudden anxiety, this could help you feel calmer.

Basel, Canton of Basel-City
NCT07374211Not yet recruiting
Esketamine for breast cancer surgery patients with severe depression

This trial tests whether a medication called esketamine, given during breast cancer surgery, can help reduce feelings of depression and anxiety after the operation. It is for women who are already experiencing severe depressive symptoms before surgery.

NCT07374198Not yet recruiting
Esketamine during breast cancer surgery to reduce depression

This study tests whether giving a medication called esketamine during breast cancer surgery can help reduce feelings of depression and anxiety after the operation. If you are having breast cancer surgery and have been feeling down, this treatment might support your emotional well-being during recovery.

NCT07367542Not yet recruiting
Esketamine for emotional distress during breast cancer surgery

This trial tests whether a medicine called esketamine, given during breast cancer surgery, can help reduce negative emotions like anxiety or depression before and after the operation. It may help you feel more emotionally stable during your treatment.

Beijing
NCT06752759Recruiting· Phase 3
Ketamine mist for depression

This trial tests if a ketamine mist you breathe in can help treat moderate to severe depression. It is for adults who are not helped enough by other treatments.

Brooklyn, New York
NCT07139106Not yet recruiting· Phase 4
Ketamine for suicidal thoughts in depression

This study tests whether ketamine can help reduce suicidal thoughts in people with depression. It also looks at how ketamine affects a brain receptor that may be linked to mood and stress, to learn why it might help.

New York, New York

Hear when a new Depressive Symptoms Mild to Moderate in Severity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.